Activiomics Raises $800K in Funding
March 18, 2011
Activiomics Raises $800K in Funding
The investment will be used to further grow partnerships with pharma and biotech companies as well as to pursue identification of prognostic and diagnostic protein biomarkers for cancer, the company said.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Activiomics Inks Deal with UCB; Aims to Raise $1M in Venture Funding Early Next Year
December 10, 2010 / ProteoMonitor - Phosphoproteomics Startup Focuses on Cell-Signaling Pathways, Signs Deal with GSK
April 23, 2010 / ProteoMonitor - Evotec to Use PhosphoScout Platform in Oncology Biomarker Alliance with Roche
July 1, 2011 / ProteoMonitor - Phosphoproteomic Screens Elucidate Feedback Loop Linked to mTOR Inhibitor Resistance
June 17, 2011 / ProteoMonitor - Researchers ID Off-Target Protein-Kinase Binding Tied to HIV Drug's Cancer Efficacy
April 29, 2011 / ProteoMonitor